These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18207698)

  • 1. CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS.
    Dittel BN
    Brain Behav Immun; 2008 May; 22(4):421-30. PubMed ID: 18207698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation.
    Veremeyko T; Yung AWY; Dukhinova M; Kuznetsova IS; Pomytkin I; Lyundup A; Strekalova T; Barteneva NS; Ponomarev ED
    Front Immunol; 2018; 9():50. PubMed ID: 29422898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of microglia in CNS autoimmunity.
    Goldmann T; Prinz M
    Clin Dev Immunol; 2013; 2013():208093. PubMed ID: 23840238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL12 in control of neuroinflammation.
    Momcilović M; Mostarica-Stojković M; Miljković D
    Immunol Res; 2012 Apr; 52(1-2):53-63. PubMed ID: 22392052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
    Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
    Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-recognition of a myelin peptide by CD8+ T cells in the CNS is not sufficient to promote neuronal damage.
    Reuter E; Gollan R; Grohmann N; Paterka M; Salmon H; Birkenstock J; Richers S; Leuenberger T; Brandt AU; Kuhlmann T; Zipp F; Siffrin V
    J Neurosci; 2015 Mar; 35(12):4837-50. PubMed ID: 25810515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging of lymphocytes in the CNS reveals different behaviour of naïve T cells in health and autoimmunity.
    Herz J; Paterka M; Niesner RA; Brandt AU; Siffrin V; Leuenberger T; Birkenstock J; Mossakowski A; Glumm R; Zipp F; Radbruch H
    J Neuroinflammation; 2011 Oct; 8():131. PubMed ID: 21978405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
    Aggelakopoulou M; Kourepini E; Paschalidis N; Panoutsakopoulou V
    J Immunol; 2016 Jun; 196(12):4947-56. PubMed ID: 27183630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis.
    von Kutzleben S; Pryce G; Giovannoni G; Baker D
    Immunology; 2017 Apr; 150(4):444-455. PubMed ID: 27925187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
    Batoulis H; Addicks K; Kuerten S
    Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
    Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The iNOS Activity During an Immune Response Controls the CNS Pathology in Experimental Autoimmune Encephalomyelitis.
    Sonar SA; Lal G
    Front Immunol; 2019; 10():710. PubMed ID: 31019516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous T Cell Receptor Rearrangement Represses Aggressive Central Nervous System Autoimmunity in a TcR-Transgenic Model on the Non-Obese Diabetic Background.
    Yeola AP; Ignatius Arokia Doss PM; Baillargeon J; Akbar I; Mailhot B; Balood M; Talbot S; Anderson AC; Lacroix S; Rangachari M
    Front Immunol; 2019; 10():3115. PubMed ID: 32010149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple Sclerosis and T Lymphocytes: An Entangled Story.
    Legroux L; Arbour N
    J Neuroimmune Pharmacol; 2015 Dec; 10(4):528-46. PubMed ID: 25946987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is damage in central nervous system due to inflammation?
    Chavarria A; Alcocer-Varela J
    Autoimmun Rev; 2004 Jun; 3(4):251-60. PubMed ID: 15246020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
    Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
    Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism.
    Ponomarev ED; Dittel BN
    J Immunol; 2005 Apr; 174(8):4678-87. PubMed ID: 15814692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.